Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity have?
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity has 1,510 citations in the OpenAlex counts ScholarIQ stores.
When was Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity published?
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity has 2023 year in the ScholarIQ index.
What is the open-access status of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity?
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity has bronze oa status in the ScholarIQ index.
What is the DOI of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity?
The DOI for Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity is on the source record.
What is the PMID of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity?
The PMID for Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity is on the source record.
What is the OpenAlex record for Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity?
The OpenAlex for Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity is on the source record.